Northern Trust’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5M | Buy |
170,736
+29,782
| +21% | +$873K | ﹤0.01% | 2458 |
|
|
2025
Q1 | $3.62M | Buy |
140,954
+1,666
| +1% | +$42.8K | ﹤0.01% | 2594 |
|
|
2024
Q4 | $4.02M | Buy |
139,288
+9,649
| +7% | +$279K | ﹤0.01% | 2634 |
|
|
2024
Q3 | $3.08M | Buy |
129,639
+48,170
| +59% | +$1.14M | ﹤0.01% | 2735 |
|
|
2024
Q2 | $1.41M | Buy |
81,469
+40,830
| +100% | +$706K | ﹤0.01% | 3087 |
|
|
2024
Q1 | $907K | Buy |
40,639
+754
| +2% | +$16.8K | ﹤0.01% | 3354 |
|
|
2023
Q4 | $731K | Buy |
39,885
+4,825
| +14% | +$88.5K | ﹤0.01% | 3422 |
|
|
2023
Q3 | $609K | Sell |
35,060
-788
| -2% | -$13.7K | ﹤0.01% | 3461 |
|
|
2023
Q2 | $652K | Buy |
35,848
+25,392
| +243% | +$462K | ﹤0.01% | 3477 |
|
|
2023
Q1 | $179K | Sell |
10,456
-792
| -7% | -$13.6K | ﹤0.01% | 3903 |
|
|
2022
Q4 | $261K | Buy |
11,248
+2,235
| +25% | +$51.9K | ﹤0.01% | 3740 |
|
|
2022
Q3 | $200K | Buy |
9,013
+2,075
| +30% | +$46K | ﹤0.01% | 3875 |
|
|
2022
Q2 | $134K | Sell |
6,938
-28,307
| -80% | -$547K | ﹤0.01% | 4062 |
|
|
2022
Q1 | $1.26M | Buy |
35,245
+11,614
| +49% | +$415K | ﹤0.01% | 3319 |
|
|
2021
Q4 | $2.06M | Buy |
23,631
+3,174
| +16% | +$276K | ﹤0.01% | 3211 |
|
|
2021
Q3 | $2.35M | Buy |
+20,457
| New | +$2.35M | ﹤0.01% | 3203 |
|